TGF-β1 peptide-based inhibitor P144 ameliorates renal fibrosis after ischemia-reperfusion injury by modulating alternatively activated macrophages.
TGF-β1 peptide-based inhibitor P144 ameliorates renal fibrosis after ischemia-reperfusion injury by modulating alternatively activated macrophages.
复制标题
DOI：
10.1111/cpr.13299
复制
发表时间：
2022
期刊：
影响因子：
--
通讯作者：
Chen Xiangmei
中科院分区：
文献类型：
--
作者：
Li Delun;Zhang Jian;Yuan Siyu;Wang Chao;Chang Jiakai;Tong Yan;Liu Ran;Sang Tian;Li Lili;Li Jijun;Ouyang Qing;Chen Xiangmei
TGF-β1 peptide-based inhibitor P144 ameliorates renal fibrosis after ischemia-reperfusion injury by modulating alternatively activated macrophages. Cell Prolif. 2022 Oct;55(10):e13299. doi: 10.1111/cpr.13299. Epub 2022 Jun 28. PMID: 35762283; PMCID: PMC9528764.
